PREX1 and breast cancer: Consistent with our previous immunohistochemistry and bioinformatics analyses [15, 20], RNA-seq expression data revealed higher PREX1 levels in luminal breast cancer specimens relative to normal samples from the same patients (p = 7.15e–11, n = 168) (Figure 5A).